Brookfield Corporation (NYSE:BN) Given Consensus Recommendation of “Moderate Buy” by Analysts

Brookfield Corporation (NYSE:BN) has been given an average recommendation of “Moderate Buy” by the fifteen analysts that are covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation, twelve have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $56.8182.

Several analysts have issued reports on the stock. JPMorgan Chase & Co. increased their price objective on shares of Brookfield from $60.00 to $62.00 and gave the company an “overweight” rating in a research report on Tuesday, May 12th. TD Securities restated a “buy” rating and issued a $60.00 target price on shares of Brookfield in a research note on Tuesday, May 19th. TD raised their price target on shares of Brookfield from $59.00 to $60.00 and gave the company a “buy” rating in a report on Tuesday, May 19th. Scotia lifted their price target on shares of Brookfield from $48.50 to $53.00 and gave the stock a “sector outperform” rating in a research note on Friday, May 15th. Finally, National Bank Financial boosted their price objective on shares of Brookfield from $58.00 to $60.00 and gave the stock an “outperform” rating in a report on Friday, May 15th.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. Fulcrum Equity Management acquired a new stake in Brookfield during the 2nd quarter valued at approximately $206,000. Revolve Wealth Partners LLC acquired a new position in shares of Brookfield in the 2nd quarter valued at approximately $366,000. Allied Private Wealth LLC acquired a new position in shares of Brookfield in the 2nd quarter valued at approximately $129,000. Tactive Advisors LLC boosted its stake in shares of Brookfield by 12.3% during the 2nd quarter. Tactive Advisors LLC now owns 9,829 shares of the company’s stock valued at $419,000 after buying an additional 1,080 shares during the last quarter. Finally, Chemistry Wealth Management LLC boosted its stake in shares of Brookfield by 0.8% during the 2nd quarter. Chemistry Wealth Management LLC now owns 445,436 shares of the company’s stock valued at $18,971,000 after buying an additional 3,669 shares during the last quarter. Institutional investors and hedge funds own 61.60% of the company’s stock.

Brookfield Stock Performance

Shares of NYSE:BN opened at $43.07 on Friday. The business’s 50-day simple moving average is $44.77 and its 200 day simple moving average is $44.59. The company has a market cap of $105.58 billion, a P/E ratio of 84.46 and a beta of 1.54. The company has a debt-to-equity ratio of 1.54, a quick ratio of 1.20 and a current ratio of 1.32. Brookfield has a one year low of $37.93 and a one year high of $49.56.

Brookfield Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Monday, June 15th were paid a dividend of $0.07 per share. The ex-dividend date was Monday, June 15th. This represents a $0.28 annualized dividend and a dividend yield of 0.7%. Brookfield’s dividend payout ratio (DPR) is currently 54.90%.

About Brookfield

Brookfield Corporation (NYSE:BN) is a global alternative asset manager that specializes in real assets. The company invests in and operates businesses across real estate, infrastructure, renewable power and energy, private equity and credit. Its activities span both ownership and active management of physical assets as well as the operation of investment funds and vehicles that provide institutional and retail investors access to long‑lived, cash‑generating assets.

Brookfield’s services include asset management, direct investing, property development and the operation of infrastructure and energy businesses.